Pharmabiz6h
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...
Medscape4d
Tocilizumab: The First Interleukin-6-Receptor Inhibitor
Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL ... modifying antirheumatic drugs. A large clinical trial ...
Nature15d
IL-1 trap go-ahead
The drug is a fusion protein comprising the human interleukin (IL)-1 type 1 receptor ... drugs including Kinaret (anakinra), an IL-1 receptor antagonist approved to treat rheumatoid arthritis ...
Monthly Prescribing Reference25d
February 2025 Recap: Drug Pipeline Updates
BLA accepted for review Dupilumab (Regeneron and Sanofi) Interleukin-4 receptor alpha antagonist Treatment of ... Anti-programmed death receptor-1 (PD-1) therapy For the treatment of patients ...